1,240 research outputs found
Toward precision Fermi liquid theory in flatland
The ultra-cold and weakly-coupled Fermi gas in two spatial dimensions is
studied in an effective field theory framework. Universal corrections to the
energy density are computed to three orders in the interaction strength with
special consideration given to the scale ambiguity associated with the
non-trivial renormalization of the singular contact interactions. The isotropic
superfluid gap is obtained to next-to-leading order, and nonuniversal
contributions to the energy density due to effective range effects, p-wave
interactions and three-body forces are computed. Results are compared with
precise Monte Carlo simulations of the energy density and the contact in the
weakly-coupled attractive and repulsive Fermi liquid regimes. In addition, the
known all-orders sum of ladder and ring diagrams is compared with Monte Carlo
simulations at weak coupling and beyond.Comment: 34 pages, 17 figure
WRF (Weather Research and Forecasting) model and radiative methods for cloud top height retrieval along the EUSO-SPB1 trajectory
Deep-learning based reconstruction of the shower maximum Xmax using the water-Cherenkov detectors of the Pierre Auger Observatory
Extraction of the muon signals recorded with the surface detector of the Pierre Auger Observatory using recurrent neural networks
NK cells and other innate lymphoid cells in hematopoietic stem cell transplantation
Natural killer (NK) cells play a major role in the T-cell depleted haploidentical hematopoietic stem cell transplantation (haplo-HSCT) to cure high-risk leukemias. NK cells belong to the expanding family of innate lymphoid cells (ILCs). At variance with NK cells, the other ILC populations (ILC1/2/3) are non-cytolytic, while they secrete different patterns of cytokines. ILCs provide host defenses against viruses, bacteria, and parasites, drive lymphoid organogenesis, and contribute to tissue remodeling. In haplo-HSCT patients, the extensive T-cell depletion is required to prevent graft-versus-host disease (GvHD) but increases risks of developing a wide range of life-threatening infections. However, these patients may rely on innate defenses that are reconstituted more rapidly than the adaptive ones. In this context, ILCs may represent important players in the early phases following transplantation. They may contribute to tissue homeostasis/remodeling and lymphoid tissue reconstitution. While the reconstitution of NK cell repertoire and its role in haplo-HSCT have been largely investigated, little information is available on ILCs. Of note, CD34+ cells isolated from different sources of HSC may differentiate in vitro toward various ILC subsets. Moreover, cytokines released from leukemia blasts (e.g., IL-1β) may alter the proportions of NK cells and ILC3, suggesting the possibility that leukemia may skew the ILC repertoire. Further studies are required to define the timing of ILC development and their potential protective role after HSCT
Arrival Directions of Cosmic Rays above 32 EeV from Phase One of the Pierre Auger Observatory
Multiphoton coherent manipulation in large-spin qubits
Large spin Mn2+ ions (S=5/2) diluted in a non-magnetic MgO matrix of high
crystalline symmetry are used to realize a six level system that can be
operated by means of multi-photon coherent Rabi oscillations. This spin system
has a very small anisotropy which can be tuned in-situ to reversibly transform
the system between harmonic and non-harmonic level configurations. Decoherence
effects are strongly suppressed as a result of the quasi-isotropic electron
interaction with the crystal field and with the 55Mn nuclear spins. These
results suggest new ways of manipulating, reading and resetting spin quantum
states which can be applied to encode a qubit across several quantum levels.Comment: Published versio
Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial.
BACKGROUND: The early use of broad-spectrum antibiotics remains the cornerstone for the treatment of neonatal late onset sepsis (LOS). However, which antibiotics should be used is still debatable, as relevant studies were conducted more than 20 years ago, recruited in single centres or countries, evaluated antibiotics not in clinical use anymore and had variable inclusion/exclusion criteria and outcome measures. Moreover, antibiotic-resistant bacteria have become a major problem in many countries worldwide. We hypothesized that efficacy of meropenem as a broad-spectrum antibiotic is superior to standard of care regimens (SOC) in empiric treatment of LOS and aimed to compare meropenem to SOC in infants aged 44 weeks meeting the Goldstein criteria of sepsis, were randomized in a 1:1 ratio to receive meropenem or one of the two SOC regimens (ampicillin+gentamicin or cefotaxime+gentamicin) chosen by each site prior to the start of the study for 8-14 days. The primary outcome was treatment success (survival, no modification of allocated therapy, resolution/improvement of clinical and laboratory markers, no need of additional antibiotics and presumed/confirmed eradication of pathogens) at test-of-cure visit (TOC) in full analysis set. Stool samples were tested at baseline and Day 28 for meropenem-resistant Gram-negative organisms (CRGNO). The primary analysis was performed in all randomised patients and in patients with culture confirmed LOS. Proportions of participants with successful outcome were compared by using a logistic regression model adjusted for the stratification factors. From September 3, 2012 to November 30th 2014, total of 136 patients (instead of planned 275) in each arm were randomized; 140 (52%) were culture positive. Successful outcome at TOC was achieved in 44/136 (32%) in the meropenem arm vs. 31/135 (23%) in the SOC arm (p = 0.087). The respective numbers in patients with positive cultures were 17/63 (27%) vs. 10/77 (13%) (p = 0.022). The main reason of failure was modification of allocated therapy. Treatment emergent adverse events occurred in 72% and serious adverse events in 17% of patients, the Day 28 mortality was 6%. Cumulative acquisition of CRGNO by Day 28 occurred in 4% of patients in the meropenem and 12% in the SOC arm (p = 0.052). CONCLUSIONS: Within this study population, we found no evidence that meropenem was superior to SOC in terms of success at TOC, short term hearing disturbances, safety or mortality were similar in both treatment arms but the study was underpowered to detect the planned effect. Meropenem treatment did not select for colonization with CRGNOs. We suggest that meropenem as broad-spectrum antibiotic should be reserved for neonates who are more likely to have Gram-negative LOS, especially in NICUs where microorganisms producing extended spectrum- and AmpC type beta-lactamases are circulating
- …